MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Global Momentum in Parkinson’s Disease Therapeutics: Ten-Year Trends in Mechanisms, Modalities, and Clinical Endpoints

    L. Gutiu, A. Fuller, A. Todorova (Durham, USA)

  • Global Parkinson´s Symptoms Index Correlates with Changes in Quality of Life and Autonomy for Activities of Daily Living

    D. Santos García, B. Solano, E. Cubo, S. Escalante, L. Vela, M. Seijo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, B. Pascual Sedano, I. Pareés Moreno, I. Gastón, M. Menéndez González, M. Kurtis, C. Ordás, C. Valero, J. Ruíz Martínez, R. Alonso Redondo, SG. Coppadis (A Coruña, Spain)

  • Global Performance Patterns in the MDS-UPDRS Motor Certification Program: A five-year Analysis

    C. Falup-Pecurariu, C. Akbostanci, E. Bayram, I. Estrada-Bellmann, J. Ma, T. Mestre, I. Murasan, O. Ojo, P. Pal, M. Qamar, F. Rodriguez-Porcel, A. Sanchez Ferro (Brasov, Romania)

  • Global Roles of Nurses and Advanced Practice Providers in Parkinson’s Disease Care: Findings from an International Workforce Survey

    K. Papesh, C. Goas, N. Bryden, B. Aparente, F. Chmell, J. Miravite, A. Roszmann, L. Wei, J. Nguyen, E. Zinn, C. Kyinn, D. Tsui, ML. Greschner, S. Gould (Henderson, USA)

  • Global Trends in Parkinson’s Disease Research: A Bibliometric Snapshot (2021–2024)

    R. Mansour, F. Namnom, A. Ali, I. Hanafi (Latakia, Syrian Arab Republic)

  • Globus Pallidus Internus Deep Brain Stimulation for Dystonia in COX20-Related Mitochondrial Complex IV Deficiency (MC4DN11): First Reported Case

    R. Toklu çetinkaya, N. Durmaz çelik, S. özkan (eskişehir, Turkey)

  • GLP-1 Receptor Agonists in Movement Disorders: From Parkinson’s Disease to the Broader Spectrum — Mechanisms, Evidence, and Future Directions

    A. Dahshan (Cairo, Egypt)

  • GLP1R Expression and Parkinson’s Disease and Related Disorders in GLP-1RA–Treated Type 2 Diabetes

    KA. Woo, Y. Jang, P. Park, HJ. Kim (Seoul, Republic of Korea)

  • Glymphatic dysfunction in patients with Parkinson’s disease is associated with regional amygdala and putamen degeneration

    C. Garcia-Vicente, J. Pardo, C. Martín-Barceló, I. Roura, C. Falcon, R. Sala-Llonch, A. Campabadal, C. Uribe, N. Bargalló, O. Brengaret, C. Brenlla, C. Painous, A. Cámara, M. Buongiorno, M. Martí, Y. Compta, C. Junqué, B. Segura (Barcelona, Spain)

  • Grey Matter Volume and White Matter Microstructural Alterations in PRKN-PD

    HT. Wang, F. Xie, B. Wang, W. Luo (Hangzhou, China)

  • « Previous Page
  • 1
  • …
  • 92
  • 93
  • 94
  • 95
  • 96
  • …
  • 208
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley